Home › Liposarcoma › Texas › Houston
Pag-aaral pangklinika para sa Liposarcoma sa Houston, TX
Isang pag-aaral para sa Liposarcoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Houston. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
Nagre-recruitPhase 3
- UT MD Anderson Cancer Center, Houston
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
Nagre-recruitPhase 2
- The University of Texas MD Anderson Cancer Center, Houston
- The University of Texas, MD Anderson Cancer Center - West Houston, Houston
Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
Nagre-recruitPhase 1
- UT MD Anderson Cancer Center, Houston
STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas
Nagre-recruitPhase 1/2
- MD Anderson Cancer Center, Houston
- NEXT Houston, Houston
Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma
Nagre-recruitPhase 1/2
- UT MD Anderson Cancer Center, Houston
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
Nagre-recruitPhase 3
- M D Anderson Cancer Center, Houston
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
Nagre-recruitPhase 3
- Investigative Site, Houston
Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
Nagre-recruitPhase 1
- Texas Children's Hospital, Houston
Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma
Nagre-recruitObservasyonal na pag-aaral
- MD Anderson Cancer Center, Houston
A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
Nagre-recruitPhase 1
- MD Anderson Cancer Center, Houston
Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
Nagre-recruitPhase 1
- Houston Methodist Hospital, Houston
Pag-aaral para sa Liposarcoma sa ibang lungsod
- New York City, NY7 pag-aaral
- Boston, MA7 pag-aaral
- St. Louis, MO5 pag-aaral
- Queens, NY5 pag-aaral
- Chicago, IL5 pag-aaral
- Nashville, TN4 pag-aaral
- Miami, FL4 pag-aaral
- Tampa, FL4 pag-aaral
- Atlanta, GA4 pag-aaral
- Edison, NJ4 pag-aaral
- Seattle, WA4 pag-aaral
- Gainesville, FL3 pag-aaral
Iba pang pag-aaral sa Houston
- Non-Small Cell Lung Cancer143 pag-aaral
- Kanser sa Suso126 pag-aaral
- Kanser (lahat ng uri)124 pag-aaral
- Colorectal Cancer101 pag-aaral
- Metastatic Cancer100 pag-aaral
- Kanser sa Ovary90 pag-aaral
- Acute Myeloid Leukemia88 pag-aaral
- Kanser sa Baga78 pag-aaral
- Kanser sa Prostate73 pag-aaral
- Kanser ng Endometrium69 pag-aaral
- Melanoma61 pag-aaral
- Kanser sa Pancreas59 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.